GlassScriptPhysician profile
Wayne L Wasemiller
NPI 1396717310
$5,372.06
in general payments reported to CMS, 2019-2025
42 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,880 · 2020: $1,334 · 2021: $16.29 · 2022: $65.61 · 2023: $76.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $76.33.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $76.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $536.69 | 2019-2020 | |
| Supernus Pharmaceuticals, INC. | $451.93 | 2019-2020 | |
| Allergan, INC. | $348.03 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $332.39 | 2019-2020 | |
| Amgen INC. | $312.98 | 2019-2020 | |
| Biogen, INC. | $302.42 | 2019-2020 | |
| Emd Serono, INC. | $279.21 | 2019-2020 | |
| Mdd US Operations, LLC | $273.07 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $219.26 | 2019 | |
| Lundbeck LLC | $212.88 | 2019-2021 | |
| Ucb, INC. | $202.99 | 2019-2020 | |
| Amneal Pharmaceuticals LLC | $154.24 | 2019-2020 | |
| Livanova USA, INC. | $144.15 | 2019-2020 | |
| Kyowa Kirin, INC. | $141.21 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $135.43 | 2019-2020 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wayne Wasemiller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.